Candel Therapeutics, Inc. CADL Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s common stock?
- Candel Therapeutics, Inc. (CADL) reported common stock of $733K in Q1 2026.
- How has Candel Therapeutics, Inc.'s common stock changed year-over-year?
- Candel Therapeutics, Inc.'s common stock increased by 48.7% year-over-year, from $493K to $733K.
- What is the long-term trend for Candel Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s common stock has grown at a 36.5% compound annual growth rate (CAGR), from $116K to $550K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).